4.7 Review

The hitchhiker's guide to the chemical-biological galaxy

Journal

DRUG DISCOVERY TODAY
Volume 23, Issue 3, Pages 565-574

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.drudis.2018.01.007

Keywords

-

Ask authors/readers for more resources

We are used to considering chemical and biological spaces as two different entities; although they represent a more-interconnected world, in fact they represent a Yin-Yang concept in drug discovery. Chemical-biological space is as vast as the universe and, as Douglas Adams famously said, 'Space is big. You just won't believe how vastly, hugely, mind-bogglingly big it is'. However, many researchers are convinced that it is not so infinite, and are designing computational and experimental tools to help identify and explore all possible chemical-biological space. Here, we provide an analysis of their approaches and discuss possible future research studies.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Chemistry, Medicinal

Identification of a novel DGKα inhibitor for XLP-1 therapy by virtual screening

Suresh Velnati, Elisa Ruffo, Alberto Massarotti, Maria Talmon, Konduru Sai Sandeep Varma, Alessandro Gesu, Luigia Grazia Fresu, Andrew L. Snow, Alessandra Bertoni, Daniela Capello, Gian Cesare Tron, Andrea Graziani, Gianluca Baldanzi

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)

Article Chemistry, Medicinal

Bio-Inspired Dual-Selective BCL-2/c-MYC G-Quadruplex Binders: Design, Synthesis, and Anticancer Activity of Drug-like Imidazo[2,1-i]purine Derivatives

Sveva Pelliccia, Jussara Amato, Domenica Capasso, Sonia Di Gaetano, Alberto Massarotti, Marialuisa Piccolo, Carlo Irace, Gian Cesare Tron, Bruno Pagano, Antonio Randazzo, Ettore Novellino, Mariateresa Giustiniano

JOURNAL OF MEDICINAL CHEMISTRY (2020)

Article Biochemistry & Molecular Biology

Structure activity relationship studies on Amb639752: toward the identification of a common pharmacophoric structure for DGK? inhibitors

Suresh Velnati, Alberto Massarotti, Annamaria Antona, Maria Talmon, Luigia Grazia Fresu, Alessandra Silvia Galetto, Daniela Capello, Alessandra Begoni, Valentina Mercalli, Andrea Graziani, Gian Cesare Tron, Gianluca Baldanzi

JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2020)

Article Chemistry, Organic

Photocatalytic Isocyanide-Based Multicomponent Domino Cascade toward the Stereoselective Formation of Iminofurans

Sveva Pelliccia, Antonella Ilenia Alfano, Paolo Luciano, Ettore Novellino, Alberto Massarotti, Gian Cesare Tron, Davide Ravelli, Mariateresa Giustiniano

JOURNAL OF ORGANIC CHEMISTRY (2020)

Article Biochemistry & Molecular Biology

Establishing Trypanosoma cruzi farnesyl pyrophosphate synthase as a viable target for biosensor driven fragment-based lead discovery

Giulia Opassi, Helena Nordstrom, Arne Lundin, Valeria Napolitano, Francesca Magari, Tom Dzus, Gerhard Klebe, U. Helena Danielson

PROTEIN SCIENCE (2020)

Article Biochemistry & Molecular Biology

A real-time cell-binding assay reveals dynamic features of STxB-Gb3 cointernalization and STxB-mediated cargo delivery into cancer cells

Joao Encarnacao, Valeria Napolitano, Giulia Opassi, U. Helena Danielson, Grzegorz Dubin, Grzegorz M. Popowicz, Helene Munier-Lehmann, Jos Buijs, Karl Andersson, Hanna Bjorkelund

FEBS LETTERS (2020)

Article Chemistry, Medicinal

Discovery of Highly Potent Benzimidazole Derivatives as Indoleamine 2,3-Dioxygenase-1 (IDO1) Inhibitors: From Structure-Based Virtual Screening to in Vivo Pharmacodynamic Activity

Marta Serafini, Enza Torre, Silvio Aprile, Erika Del Grosso, Alessandro Gesu, Alessia Griglio, Giorgia Colombo, Cristina Travelli, Salvatore Paiella, Annalisa Adamo, Elena Orecchini, Alice Coletti, Maria Teresa Pallotta, Stefano Ugel, Alberto Massarotti, Tracey Pirali, Silvia Fallarini

JOURNAL OF MEDICINAL CHEMISTRY (2020)

Article Chemistry, Medicinal

Essential Medicinal Chemistry of Essential Medicines

Marta Serafini, Sarah Cargnin, Alberto Massarotti, Tracey Pirali, Armando A. Genazzani

JOURNAL OF MEDICINAL CHEMISTRY (2020)

Article Oncology

Psychotropic Drugs Show Anticancer Activity by Disrupting Mitochondrial and Lysosomal Function

Marco Varalda, Annamaria Antona, Valentina Bettio, Konkonika Roy, Ajay Vachamaram, Vaibhav Yellenki, Alberto Massarotti, Gianluca Baldanzi, Daniela Capello

FRONTIERS IN ONCOLOGY (2020)

Article Chemistry, Medicinal

Therapeutic peptides for the treatment of cystic fibrosis: Challenges and perspectives

Valentina Sala, Sophie Julie Cnudde, Alessandra Murabito, Alberto Massarotti, Emilio Hirsch, Alessandra Ghigo

Summary: Cystic fibrosis (CF) is a common rare genetic disease affecting over 70,000 people worldwide, characterized by lung blockage and chronic infections. Peptides hold promise as therapeutics for respiratory diseases like CF due to their high specificity, efficacy, and low toxicity, but face challenges like retention within mucus, proteolysis, immunogenicity, and aggregation in the development process. Solutions to overcome these issues and advancements in peptide design are being explored.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)

Article Chemistry, Medicinal

What's in a Name? Drug Nomenclature and Medicinal Chemistry Trends using INN Publications

Marta Serafini, Sarah Cargnin, Alberto Massarotti, Gian Cesare Tron, Tracey Pirali, Armando A. Genazzani

Summary: This article explains the process of assigning common drug names by the World Health Organization and analyzes chemical entities from 2000 to 2021, describing changes in chemical structure, newer therapeutic targets (such as kinases), significant increases in the use of fluorine and heterocycles, as well as progressive increases in molecular weight. These analyses also reveal small signs of change, such as the rise in spirocyclic scaffolds and small rings, and the emergence of unconventional structural moieties that may predict future trends.

JOURNAL OF MEDICINAL CHEMISTRY (2021)

Review Chemistry, Multidisciplinary

Medicinal Chemistry of Isocyanides

Alberto Massarotti, Francesca Brunelli, Silvio Aprile, Mariateresa Giustiniano, Gian Cesare Tron

Summary: Isocyanides, with their metal coordinating properties, have carved out a niche in ecological systems through evolution. Despite their potential biological activity, medicinal chemists have been skeptical of isocyanides due to concerns about reactivity and stability. This review aims to showcase the rich biological activity of isocyanide-containing molecules and advocate for their consideration in future drug design.

CHEMICAL REVIEWS (2021)

Article Chemistry, Medicinal

The [1,2,4]Triazolo[4,3-a]pyridine as a New Player in the Field of IDO1 Catalytic Holo-Inhibitors

Silvia Fallarini, Irene P. Bhela, Silvio Aprile, Enza Torre, Alice Ranza, Elena Orecchini, Eleonora Panfili, Maria T. Pallotta, Alberto Massarotti, Marta Serafini, Tracey Pirali

Summary: Inhibitors of indoleamine 2,3-dioxygenase 1 (IDO1) are considered a promising strategy in cancer immunotherapy, and recent studies have revealed additional roles of IDO1 beyond its catalytic activity. A novel class of compounds, originated from a structure-based virtual screening on IDO1 active site, has shown improved potency, metabolic stability, and selectivity after rational and in silico-guided design of analogues.

CHEMMEDCHEM (2021)

Article Multidisciplinary Sciences

PI(3,4)P2-mediated cytokinetic abscission prevents early senescence and cataract formation

Federico Gulluni, Lorenzo Prever, Huayi Li, Petra Krafcikova, Ilaria Corrado, Wen-Ting Lo, Jean Piero Margaria, Anlu Chen, Maria Chiara De Santis, Sophie J. Cnudde, Joseph Fogerty, Alex Yuan, Alberto Massarotti, Nasrin Torabi Sarijalo, Oscar Vadas, Roger L. Williams, Marcus Thelen, David R. Powell, Markus Schueler, Michael S. Wiesener, Tamas Balla, Hagit N. Baris, Dov Tiosano, Brian M. McDermott, Brian D. Perkins, Alessandra Ghigo, Miriam Martini, Volker Haucke, Evzen Boura, Giorgio Roberto Merlo, David A. Buchner, Emilio Hirsch

Summary: The cytokinetic process in the lens, which depends on PI3K-C2alpha, PI(3,4)P-2, and VPS36, is essential for preventing premature senescence and cataract. Loss of these components impairs cytokinesis and leads to cell damage, triggering senescence in the lens of fish, mice, and humans.

SCIENCE (2021)

Article Biochemistry & Molecular Biology

The SNAP-tag technology revised: an effective chemo-enzymatic approach by using a universal azide-based substrate

Rosa Merlo, Diego Caprioglio, Michele Cillo, Anna Valenti, Rosanna Mattossovich, Castrese Morrone, Alberto Massarotti, Franca Rossi, Riccardo Miggiano, Antonio Leonardi, Alberto Minassi, Giuseppe Perugino

Summary: The SNAP-tag (R) technology for protein/enzyme labeling can be enhanced and improved by using a chemo-enzymatic approach with a BG-substrate containing an azide group for subsequent conjugation.

JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2021)

Review Pharmacology & Pharmacy

Illuminating the druggable genome: Pathways to progress

Karlie R. Sharma, Christine M. Colvis, Griffih P. Rodgers, Douglas M. Sheeley

Summary: There are many genes within the druggable genome that have not been studied, and the US National Institutes of Health's program provides resources to explore these genes, with the potential for rapid impact on human health.

DRUG DISCOVERY TODAY (2024)

Review Pharmacology & Pharmacy

Unravelling the potential of mitochondria-targeted liposomes for enhanced cancer treatment

Mohammad Sameer Khan, B. H. Jaswanth Gowda, Waleed H. Almalki, Tanuja Singh, Amirhossein Sahebkar, Prashant Kesharwani

Summary: Mitochondria-specific functional liposomes hold great potential for cancer therapy. This review discusses the association between mitochondria and tumor formation, as well as the advantages of liposomes in delivering drugs to mitochondria.

DRUG DISCOVERY TODAY (2024)

Review Pharmacology & Pharmacy

Multiorgan locked-state model of chronic diseases and systems pharmacology opportunities

Choong Yong Ung, Cristina Correia, Hu Li, Christopher M. Adams, Jennifer J. Westendorf, Shizhen Zhu

Summary: With increasing human life expectancy, the global medical burden of chronic diseases is growing. Chronic diseases often involve malfunctioning of multiple organs, and understanding the interorgan crosstalk is crucial to understanding the etiology of chronic diseases. Researchers have proposed the locked-state model (LoSM) and cutting-edge systems biology and artificial intelligence strategies to decipher chronic multiorgan locked states. The findings have important clinical implications for improving treatments for chronic diseases.

DRUG DISCOVERY TODAY (2024)